Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |